Buchang Pharmaceutical announced that the holding subsidiary Buchang Golden Key plans to jointly invest with Yin Weiqun to establish Zhuhai Daqian Mobuchang Pharmaceutical Technology Co., Ltd., with a registered capital of 1 million yuan. Bu Chang Gold Key invested RMB 510,000, with a shareholding ratio of 51%. After the establishment of a new company, it may be affected by factors such as macroeconomic policy regulation, market changes, and management, and there is uncertainty about subsequent investment returns.

Buchang Pharmaceutical announced that the holding subsidiary Buchang Golden Key plans to jointly invest with Yin Weiqun to establish Zhuhai Daqian Mobuchang Pharmaceutical Technology Co., Ltd., with a registered capital of 1 million yuan. Bu Chang Gold Key invested RMB 510,000, with a shareholding ratio of 51%. After the establishment of a new company, it may be affected by factors such as macroeconomic policy regulation, market changes, and management, and there is uncertainty about subsequent investment returns.